World's Best Scientists 2026 revealed!
Rosette Lidereau

Rosette Lidereau

D-Index & Metrics

Medicine

D-Index
95
Citations
34106
World Ranking
10053
National Ranking
308

Overview

Rosette Lidereau is affiliated with the Institute Curie in France. Their research spans several interconnected fields within the biomedical sciences, primarily focusing on biochemistry, genetics, molecular biology, and medicine.

Their work frequently appears in notable publication venues, including:

  • Cells
  • Genome Medicine
  • Human Mutation
  • Cancers
  • Molecular Oncology

The research topics explored by Lidereau cover a range of areas critical to understanding cancer and genetic disorders. These include:

  • Genetics and Neurodevelopmental Disorders
  • Nuclear Receptors and Signaling
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • BRCA gene mutations in cancer
  • Genomic variations and chromosomal abnormalities
  • CRISPR and Genetic Engineering

Lidereau's scientific contributions also fall within specific subfields such as molecular biology, genetics, oncology, cancer research, and pulmonary and respiratory medicine.

Several frequent collaborators contribute to the breadth and depth of their research efforts. These coauthors include:

  • Keltouma Driouch
  • Ivan Bièche
  • Sandrine M. Caputo
  • François Lallemand
  • Zakia Tariq

Their recent publications demonstrate focus on molecular functions and genetic factors related to cancer development and progression. Selected titles include:

  • Molecular Functions of WWOX Potentially Involved in Cancer Development, 2021, Cells
  • Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study, 2021, Genome Medicine
  • Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I, 2021, Human Mutation
  • 5' Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints, 2021, Cancers
  • The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis, 2020, Scientific Reports

Best Publications

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,

    Christine Desmedt;Fanny Piette;Sherene Loi;Yixin Wang

  • The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Alfredo Criollo;Alfredo Criollo;Alfredo Criollo

  • The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

    Magali Olivier;Anita Langerød;Patrizia Carrieri;Jonas Bergh

  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub

  • Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

    Chantal Escot;Charles Theillet;Rosette Lidereau;Frederique Spyratos

  • Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43

    Philippe Berthon;Antoine Valeri;Annick Cohen-Akenine;Eric Drelon

  • Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas

    Igor Girault;Sengül Tozlu;Rosette Lidereau;Ivan Bièche

  • Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia

    Iqbal Unnisa Ali;Rosette Lidereau;Charles Theillet;Robert Callahan

  • Genetic alterations in breast cancer.

    Ivan Bièche;Rosette Lidereau

  • Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

    Alain Latil;Ivan Bièche;Dominique Vidaud;Rosette Lidereau

  • Down-regulation of BRCA1 Expression by miR-146a and miR-146b-5p in Triple Negative Sporadic Breast Cancers

    Amandine I Garcia;Monique Buisson;Pascale Bertrand;Ruth Rimokh

  • A refined molecular taxonomy of breast cancer

    M Guedj;L Marisa;A de Reynies;B Orsetti

  • Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

    Ivan Bièche;Florence Lerebours;Sengül Tozlu;Marc Espie

  • Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical Applications

    Ivan Bièche;Peter Onody;Ingrid Laurendeau;Martine Olivi

  • Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

    Ivan Bièche;Ingrid Laurendeau;Sengül Tozlu;Martine Olivi

  • Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

    Charles Theillet;Rosette Lidereau;Chantal Escot;Paula Hutzell

  • Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach

    S Tozlu;I Girault;S Vacher;J Vendrell

Frequent Co-Authors

Ivan Bièche
Ivan Bièche Institute Curie
Robert Callahan
Robert Callahan National Institutes of Health
Olivier Cussenot
Olivier Cussenot Université Paris Cité
Charles Theillet
Charles Theillet University of Montpellier
Giorgio R. Merlo
Giorgio R. Merlo University of Turin
Michel Vidaud
Michel Vidaud Université Paris Cité
Yves-Jean Bignon
Yves-Jean Bignon Centre Jean Perrin
Thierry Frebourg
Thierry Frebourg Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a medical career in the USA, numerous online degrees offer alternative or complementary paths in healthcare. Many learners explore healthcare administration programs to build foundational knowledge in healthcare leadership, policy, and facility management—vital skills for those interested in running hospitals or clinics.

Nursing remains a popular route, especially for registered nurses seeking to advance. RN to FNP bridge programs help working nurses transition into family nurse practitioner roles, expanding their clinical scope and job opportunities.

For those drawn to preventive care and lifestyle medicine, an online nutritionist degree teaches the science of diet and wellness, preparing graduates for rewarding positions in patient counseling or public health.

Aspiring healthcare executives can also consider accredited MHA programs, which deliver advanced management and leadership training necessary for high-level healthcare administration roles.

These flexible online pathways can boost your expertise and expand your career options in the dynamic field of medicine and healthcare.

Best Scientists Citing Rosette Lidereau

Trending Scientists

Recently Published Articles